Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, claims Roots Analysis
Report Keywords- Cell Therapy, Therapy, Manufacturing, RootsAnalysis, Report, Biotech, Analysis   The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity   Roots Analysis has...
0 Comments 0 Shares